Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats

The aim of the present study was to investigate the potential antioxidant and Hepatoprotective activities of tranilast against TAA-induced liver fibrosis in rats. Methods: Liver fibrosis was induced in rats by intra peritoneal injection of TAA (200 mg/kg) for 6 weeks. Tranilast was administered oral...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ramadan A., Nehal A. Afifi, Nemat Z. Yassin, Rehab F. Abdel-Rahman, Sahar S. Abd El-Rahman, Hany M. Fayed
Formato: article
Lenguaje:EN
Publicado: Egyptian Society for Animal Management 2017
Materias:
rat
Acceso en línea:https://dx.doi.org/10.21608/javs.2017.62131
https://doaj.org/article/e94b12a5a6e942e4b79daf9082d98e40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e94b12a5a6e942e4b79daf9082d98e40
record_format dspace
spelling oai:doaj.org-article:e94b12a5a6e942e4b79daf9082d98e402021-12-02T17:02:54ZAntioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Ratshttps://dx.doi.org/10.21608/javs.2017.621311687-40722090-3308https://doaj.org/article/e94b12a5a6e942e4b79daf9082d98e402017-10-01T00:00:00Zhttps://javs.journals.ekb.eg/article_62131.htmlhttps://doaj.org/toc/1687-4072https://doaj.org/toc/2090-3308The aim of the present study was to investigate the potential antioxidant and Hepatoprotective activities of tranilast against TAA-induced liver fibrosis in rats. Methods: Liver fibrosis was induced in rats by intra peritoneal injection of TAA (200 mg/kg) for 6 weeks. Tranilast was administered orally at a dose of 150 and 300mg/kg for 6 weeks before induction of liver fibrosis. Results: Injection of TAA induced hepatic fibrosis that was manifested by a significant increase in the activities of aminotransferases and total bilirubin with a significant decrease in total protein and albumin in serum. Liver homogenate of TAA rats had the lower content of reduced glutathione (GSH) and superoxide dismutase (SOD) with increased levels of the hepatic malondialdehyde. Histological data presented marked damage in liver sections of TAA rats. Oral dosing of tranilast for 6 weeks before induction of liver fibrosis reversed these altered parameters near to normal values. These results suggest that tranilast could afford significant protection and antioxidant effect in prevention of liver fibrosis.Ramadan A.Nehal A. Afifi Nemat Z. YassinRehab F. Abdel-Rahman Sahar S. Abd El-RahmanHany M. Fayed Egyptian Society for Animal Managementarticlehepatic fibrosisthioacetamidetranilastliverratZoologyQL1-991Veterinary medicineSF600-1100Animal biochemistryQP501-801ENJournal of Applied Veterinary Sciences, Vol 2, Iss 1, Pp 9-17 (2017)
institution DOAJ
collection DOAJ
language EN
topic hepatic fibrosis
thioacetamide
tranilast
liver
rat
Zoology
QL1-991
Veterinary medicine
SF600-1100
Animal biochemistry
QP501-801
spellingShingle hepatic fibrosis
thioacetamide
tranilast
liver
rat
Zoology
QL1-991
Veterinary medicine
SF600-1100
Animal biochemistry
QP501-801
Ramadan A.
Nehal A. Afifi
Nemat Z. Yassin
Rehab F. Abdel-Rahman
Sahar S. Abd El-Rahman
Hany M. Fayed
Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
description The aim of the present study was to investigate the potential antioxidant and Hepatoprotective activities of tranilast against TAA-induced liver fibrosis in rats. Methods: Liver fibrosis was induced in rats by intra peritoneal injection of TAA (200 mg/kg) for 6 weeks. Tranilast was administered orally at a dose of 150 and 300mg/kg for 6 weeks before induction of liver fibrosis. Results: Injection of TAA induced hepatic fibrosis that was manifested by a significant increase in the activities of aminotransferases and total bilirubin with a significant decrease in total protein and albumin in serum. Liver homogenate of TAA rats had the lower content of reduced glutathione (GSH) and superoxide dismutase (SOD) with increased levels of the hepatic malondialdehyde. Histological data presented marked damage in liver sections of TAA rats. Oral dosing of tranilast for 6 weeks before induction of liver fibrosis reversed these altered parameters near to normal values. These results suggest that tranilast could afford significant protection and antioxidant effect in prevention of liver fibrosis.
format article
author Ramadan A.
Nehal A. Afifi
Nemat Z. Yassin
Rehab F. Abdel-Rahman
Sahar S. Abd El-Rahman
Hany M. Fayed
author_facet Ramadan A.
Nehal A. Afifi
Nemat Z. Yassin
Rehab F. Abdel-Rahman
Sahar S. Abd El-Rahman
Hany M. Fayed
author_sort Ramadan A.
title Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
title_short Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
title_full Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
title_fullStr Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
title_full_unstemmed Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
title_sort antioxidant and hepatoprotective effects of tranilast against thioacetamide-induced liver fibrosis in rats
publisher Egyptian Society for Animal Management
publishDate 2017
url https://dx.doi.org/10.21608/javs.2017.62131
https://doaj.org/article/e94b12a5a6e942e4b79daf9082d98e40
work_keys_str_mv AT ramadana antioxidantandhepatoprotectiveeffectsoftranilastagainstthioacetamideinducedliverfibrosisinrats
AT nehalaafifi antioxidantandhepatoprotectiveeffectsoftranilastagainstthioacetamideinducedliverfibrosisinrats
AT nematzyassin antioxidantandhepatoprotectiveeffectsoftranilastagainstthioacetamideinducedliverfibrosisinrats
AT rehabfabdelrahman antioxidantandhepatoprotectiveeffectsoftranilastagainstthioacetamideinducedliverfibrosisinrats
AT saharsabdelrahman antioxidantandhepatoprotectiveeffectsoftranilastagainstthioacetamideinducedliverfibrosisinrats
AT hanymfayed antioxidantandhepatoprotectiveeffectsoftranilastagainstthioacetamideinducedliverfibrosisinrats
_version_ 1718381941091205120